The role of α1-adrenergic receptor subtypes in lower urinary tract symptoms

BJU International, Supplement

Volumn 88, Issue 2, 2001, Pages 27-34

  Schwinn, D A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenergic; Bladder; Prostate; Receptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN; RECEPTOR SUBTYPE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLADDER; BLADDER FUNCTION; BLADDER NECK STENOSIS; CLINICAL FEATURE; CONFERENCE PAPER; EMBRYO DEVELOPMENT; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SPINAL CORD; TISSUE DISTRIBUTION; URETHRA DISEASE; BLADDER OBSTRUCTION; CELL COMMUNICATION; CHEMISTRY; DRUG ANTAGONISM; MALE; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; URINARY TRACT; URINE RETENTION;

ADRENERGIC ALPHA-ANTAGONISTS; CELL COMMUNICATION; HUMANS; MALE; PROSTATIC HYPERPLASIA; RECEPTORS, ADRENERGIC, ALPHA-1; SPINAL CORD; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY RETENTION; URINARY TRACT;

EID: 0034797955     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.2001.00116.x     Document Type: Conference Paper

References (50)

1. Novel role for α1-adrenergic receptor subtypes in lower urinary tract symptoms
2. History and nomenclature of alpha1-adrenoceptors
3. The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: An overview
4. Comprehensive patient evaluation for benign prostatic hyperplasia
5. Medical therapy and quality of life
6. Tamsulosin: Real life clinical experience in 19, 365 patients
7. 1-adrenoceptors: Consensus update
8. 2-adrenoceptor subtypes: Therapeutic implications
9. Alpha1-adrenergic receptor subtypes in human detrusor
10. Molecular pharmacology of human alpha1-adrenergic receptors: Unique features of the alpha 1a-subtype
11. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction
12. Current trends in management of men with lower urinary tracts symptoms and benign prostatic hyperplasia
13. The pathophysiology of lower urinary tract symptoms in the ageing male population
14. Development of the urogenital system
15. Clinical evaluation of genitourinary disorders. Genitourinary disorders
16. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia
17. 1-adrenoceptor selectivity: Clinical or theoretical benefit?
18. Alpha-adrenergic blocking drugs in bladder outflow obstruction: What potential has alpha1-adrenoceptor selectivity?
19. Apha1-adrenergic receptor regulation: Basic science and clinical implications
20. Arrangement of transmembrane domains in adrenergic receptors. Similarity to bacteriorhodopsin
21. Structure and function of G protein-coupled receptors
22. A study of the adrenotropic receptors
23. Pharmacotherapy for benign prostatic hyperplasia - The potential for alpha 1-adrenoceptor subtype-specific blockade
24. Comparison of alpha-adrenergic receptor subtypes distinguished by chlorethyl-clonidine and WB4101
25. Heterogeneity of alpha1-adrenergic receptors revealed by chlorethylclonidine
26. Molecular cloning and expression of the c-DNA for a novel α-adrenergic receptor subtype
27. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor
28. 1A-adrenergic receptor
29. 1d-adrenergic receptor cDNA
30. Cloning and pharmacological characterization of human alpha1-adrenergic receptors: Sequence corrections and direct comparison with other species homologues
31. Current status of research on prostate-selective alpha1-antagonists
32. Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants
33. Characterization and localization of prostatic alpha 1-adrenoceptors using radioligand receptor binding on slide-mounted tissue section
34. 1-adrenergic subtypes in human tissues: Implications for human α-adrenergic physiology
35. 1-adrenergic subtype classification
36. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck
37. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic BPH
38. 1-adrenergic receptor subtypes in human prostate
39. Quantification and distribution of alpha1-adrenoreceptor subtype mRNAs in human prostate: Comparison of benign hypertrophied tissue and non hypertrophied tissue
40. Subtype specific regulation of human vascular alpha (1)-adrenergic receptors by vessel bed and age
41. 1-adrenergic subtypes at four distinct levels
42. Smooth muscle and parasympathetic nerve terminals in the rat urinary bladder have different subtypes of α1-adrenoceptors
43. The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c-subtype
44. A comparison of the binding and functional properties of alpha 1-adrenoceptors and area density of smooth muscle in the human, canine
45. Urinary incontinence caused by prazosin
46. α-adrenergic approach in the medical management of benign prostatic hyperplasia
47. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women
48. Controversies in the management of lower urinary tract symptoms: An overview
49. Clinical pharmacology of modern antihypertensive agents and their interaction with alpha-adrenoceptor antagonists
50. Changes in α1-adrenergic receptor (AR) subtype gene expression during bladder outlet obstruction of rate